雅仕維(01993.HK)折讓27%發代價股份支付部分收購款項
雅仕維(01993.HK)公布,有關收購目標公司的最後一筆分期付款之一部分將以現金部分支付,而餘下部分則將透過股份部分予以支付。就最後一筆分期付款而言,每股代價股份之發行價須為緊接2022年3月31日前連續五個交易日在聯交所所報之股份平均收市價(經調整後),即1.248元。
每股代價股份之發行價1.248港元較股份於補充協議日期每股收市價3.41元折讓約63.4%;及於緊接公告日期前一個交易日在聯交所所報之每股收市價1.71元折讓約27%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.